These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 16610798)

  • 21. Benzimidazole-substituted (3-phenoxypropyl)amines as histamine H3 receptor ligands.
    Aslanian R; Zhu X; Vaccaro HA; Shih NY; Piwinski JJ; Williams SM; West RE
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5032-6. PubMed ID: 18752952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and functional characterization of imbutamine analogs as histamine H3 and H4 receptor ligands.
    Geyer R; Kaske M; Baumeister P; Buschauer A
    Arch Pharm (Weinheim); 2014 Feb; 347(2):77-88. PubMed ID: 24493592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acidic elements in histamine H(3) receptor antagonists.
    Sander K; von Coburg Y; Camelin JC; Ligneau X; Rau O; Schubert-Zsilavecz M; Schwartz JC; Stark H
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1581-4. PubMed ID: 20138762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histamine H(4) receptor-RGS fusion proteins expressed in Sf9 insect cells: a sensitive and reliable approach for the functional characterization of histamine H(4) receptor ligands.
    Schneider EH; Seifert R
    Biochem Pharmacol; 2009 Sep; 78(6):607-16. PubMed ID: 19464266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of 2-arylbenzimidazoles as potent human histamine H4 receptor ligands.
    Lee-Dutra A; Arienti KL; Buzard DJ; Hack MD; Khatuya H; Desai PJ; Nguyen S; Thurmond RL; Karlsson L; Edwards JP; Breitenbucher JG
    Bioorg Med Chem Lett; 2006 Dec; 16(23):6043-8. PubMed ID: 16990005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactions of histamine H1-receptor agonists and antagonists with the human histamine H4-receptor.
    Deml KF; Beermann S; Neumann D; Strasser A; Seifert R
    Mol Pharmacol; 2009 Nov; 76(5):1019-30. PubMed ID: 19720730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 4-(omega-(alkyloxy)alkyl)-1H-imidazole derivatives as histamine H(3) receptor antagonists/agonists.
    Meier G; Krause M; Hüls A; Ligneau X; Pertz HH; Arrang JM; Ganellin CR; Schwartz JC; Schunack W; Stark H
    J Med Chem; 2004 May; 47(10):2678-87. PubMed ID: 15115409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. First metal-containing histamine H3 receptor ligands.
    Sander K; Kottke T; Hoffend C; Walter M; Weizel L; Camelin JC; Ligneau X; Schneider EH; Seifert R; Schwartz JC; Stark H
    Org Lett; 2010 Jun; 12(11):2578-81. PubMed ID: 20446742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of 4-(1H-imidazol-4(5)-ylmethyl)pyridine (immethridine) as a novel, potent, and highly selective histamine H(3) receptor agonist.
    Kitbunnadaj R; Zuiderveld OP; Christophe B; Hulscher S; Menge WM; Gelens E; Snip E; Bakker RA; Celanire S; Gillard M; Talaga P; Timmerman H; Leurs R
    J Med Chem; 2004 May; 47(10):2414-7. PubMed ID: 15115383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New high affinity H3 receptor agonists without a basic side chain.
    Kitbunnadaj R; Hoffmann M; Fratantoni SA; Bongers G; Bakker RA; Wieland K; el Jilali A; De Esch IJ; Menge WM; Timmerman H; Leurs R
    Bioorg Med Chem; 2005 Dec; 13(23):6309-23. PubMed ID: 16213736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cloning and characterization of a novel human histamine receptor.
    Morse KL; Behan J; Laz TM; West RE; Greenfeder SA; Anthes JC; Umland S; Wan Y; Hipkin RW; Gonsiorek W; Shin N; Gustafson EL; Qiao X; Wang S; Hedrick JA; Greene J; Bayne M; Monsma FJ
    J Pharmacol Exp Ther; 2001 Mar; 296(3):1058-66. PubMed ID: 11181941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity.
    Morini G; Comini M; Rivara M; Rivara S; Bordi F; Plazzi PV; Flammini L; Saccani F; Bertoni S; Ballabeni V; Barocelli E; Mor M
    Bioorg Med Chem; 2008 Dec; 16(23):9911-24. PubMed ID: 18976927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histamine H3 and H4 receptors as novel drug targets.
    Tiligada E; Zampeli E; Sander K; Stark H
    Expert Opin Investig Drugs; 2009 Oct; 18(10):1519-31. PubMed ID: 19758107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The challenge of drug discovery of a GPCR target: analysis of preclinical pharmacology of histamine H3 antagonists/inverse agonists.
    Hancock AA
    Biochem Pharmacol; 2006 Apr; 71(8):1103-13. PubMed ID: 16513092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diamine derivatives containing imidazolidinylidene propanedinitrile as a new class of histamine H3 receptor antagonists. Part I.
    Sasho S; Seishi T; Kawamura M; Hirose R; Toki S; Shimada JI
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2288-91. PubMed ID: 18353639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of a histamine H3 receptor model through structure-activity relationships for classical H3 antagonists.
    Lorenzi S; Mor M; Bordi F; Rivara S; Rivara M; Morini G; Bertoni S; Ballabeni V; Barocelli E; Plazzi PV
    Bioorg Med Chem; 2005 Oct; 13(19):5647-57. PubMed ID: 16085419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A selective human H(4)-receptor agonist: (-)-2-cyano-1-methyl-3-[(2R,5R)-5- [1H-imidazol-4(5)-yl]tetrahydrofuran-2-y] methylguanidine.
    Hashimoto T; Harusawa S; Araki L; Zuiderveld OP; Smit MJ; Imazu T; Takashima S; Yamamoto Y; Sakamoto Y; Kurihara T; Leurs R; Bakker RA; Yamatodani A
    J Med Chem; 2003 Jul; 46(14):3162-5. PubMed ID: 12825954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New 1-benzyl-4-hydroxypiperidine derivatives as non-imidazole histamine H3 receptor antagonists.
    Maslowska-Lipowicz I; Figlus M; Zuiderveld OP; Walczynski K
    Arch Pharm (Weinheim); 2008 Dec; 341(12):762-73. PubMed ID: 19009544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detailed pharmacological characterization of GT-2331 for the rat histamine H3 receptor.
    Ito S; Yoshimoto R; Miyamoto Y; Mitobe Y; Nakamura T; Ishihara A; MacNeil DJ; Kanatani A; Tokita S
    Eur J Pharmacol; 2006 Jan; 529(1-3):40-6. PubMed ID: 16316645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclopropane-based stereochemical diversity-oriented conformational restriction strategy: histamine H3 and/or H4 receptor ligands with the 2,3-methanobutane backbone.
    Watanabe M; Kobayashi T; Hirokawa T; Yoshida A; Ito Y; Yamada S; Orimoto N; Yamasaki Y; Arisawa M; Shuto S
    Org Biomol Chem; 2012 Jan; 10(4):736-45. PubMed ID: 22120611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.